Knee OA Trial Tests Diacerein - Top-Institutions - MDSpire

Knee OA Trial Tests Diacerein

Researchers compared diacerein and placebo in a 24-week randomized study involving knee osteoarthritis with MRI-confirmed effusion-synovitis.

  • By

  • Kathryn Wighton

  • March 16, 2026

  • 4 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Hospital for Special Surgery
    Hospital for Special Surgery

    New York, NY

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Musculoskeletal Imaging

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Clinical Research

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Orthopedic Surgery
    • Translational Medicine

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Imaging Research

  • #5

    University of Sydney
    University of Sydney

    Sydney, NSW

    Key Differentiators

    • Rheumatology
    • Musculoskeletal Research
    • Clinical Trials

Original Source(s)

Knee OA Trial Tests Diacerein

  • by Kathryn Wighton

  • March 16, 2026

Related Content

Outcomes and associated factors of revision procedures after failed total ankle arthroplasty: a comparative cohort analysis

Impact of Sulfate-Arsenical-Ferruginous Water on Apoptosis, Oxidative Stress, and Gene Expression of Inflammatory Mediators and MicroRNA in Human Osteoarthritic Chondrocytes Stimulated by IL-1β

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.